Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 889969

Epilepsy and pregnancy - which antiepileptic drug should we choose?


Petelin Gadze, Zeljka
Epilepsy and pregnancy - which antiepileptic drug should we choose? // Neurologia / Korczyn, Amos (ur.).
Atena: Hellenic Neurological Society, 2017. str. 16-16 (pozvano predavanje, međunarodna recenzija, sažetak, stručni)


CROSBI ID: 889969 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Epilepsy and pregnancy - which antiepileptic drug should we choose?

Autori
Petelin Gadze, Zeljka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Neurologia / Korczyn, Amos - Atena : Hellenic Neurological Society, 2017, 16-16

Skup
11th World Congress on Controversies in Neurology (CONy)

Mjesto i datum
Atena, Grčka, 23.03.2017. - 26.03.2017

Vrsta sudjelovanja
Pozvano predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
epilepsy, pregnancy, treatment

Sažetak
Women with epilepsy have a slightly higher risk for some pregnancy and birth complications and require increased surveillance during pregnancy. Although two of three women with epilepsy remain seizure free throughout pregnancy, antiepileptic drugs (AEDs) dosages may need to be adjusted and therapeutic drug monitoring should be performed, at least every 4 weeks. Due to pharmacokinetic changes during pregnancy, the most pronounced decline in serum concentrations is seen for AEDs eliminated by glucuronidation, in particular lamotrigine (LTG). Consequently, the risks for uncontrolled seizures during pregnancy need to be balanced against potential teratogenic effects of AEDs. AED pregnancy registries continue to confirm that valproate (VPA) poses a significantly increased dose-dependent risk of structural and cognitive teratogenesis, ranging from 5.6% (<750mg/day) to 24.2% (>1500mg/day). Phenytoin (PHT), phenobarbital (PB), and topiramate (TPM) likely confer an intermediate risk and LTG, oxcarbazepine (OXC), and levetiracetam (LEV) are associated with a relatively low risk of congenital malformations. Accordingly, women with epilepsy should be treated with a low-dose monotherapy during pregnancy and VPA should be avoided. Supplementary folic acid (5 mg daily dose) is recommended, because this lowers the risk of cognitive teratogenicity. Third-trimester vitamin K supplementation has been suggested for women taking enzyme-inducing AEDs (eg. CBZ, PHT, PB), based on a concern for increased risk of intracranial neonatal haemorrhage. Experiences of the Referral Centre for Epilepsy of the Ministry of Health of the Republic of Croatia in treating pregnant women with epilepsy will also be presented.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Željka Petelin Gadže (autor)


Citiraj ovu publikaciju:

Petelin Gadze, Zeljka
Epilepsy and pregnancy - which antiepileptic drug should we choose? // Neurologia / Korczyn, Amos (ur.).
Atena: Hellenic Neurological Society, 2017. str. 16-16 (pozvano predavanje, međunarodna recenzija, sažetak, stručni)
Petelin Gadze, Z. (2017) Epilepsy and pregnancy - which antiepileptic drug should we choose?. U: Korczyn, A. (ur.)Neurologia.
@article{article, author = {Petelin Gadze, Zeljka}, editor = {Korczyn, A.}, year = {2017}, pages = {16-16}, keywords = {epilepsy, pregnancy, treatment}, title = {Epilepsy and pregnancy - which antiepileptic drug should we choose?}, keyword = {epilepsy, pregnancy, treatment}, publisher = {Hellenic Neurological Society}, publisherplace = {Atena, Gr\v{c}ka} }
@article{article, author = {Petelin Gadze, Zeljka}, editor = {Korczyn, A.}, year = {2017}, pages = {16-16}, keywords = {epilepsy, pregnancy, treatment}, title = {Epilepsy and pregnancy - which antiepileptic drug should we choose?}, keyword = {epilepsy, pregnancy, treatment}, publisher = {Hellenic Neurological Society}, publisherplace = {Atena, Gr\v{c}ka} }




Contrast
Increase Font
Decrease Font
Dyslexic Font